ArticleFrontiers in pharmacology2020

An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?

Giuseppe Terrazzano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.